| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 130, 2660-2668, Copyright © 1992 by Endocrine Society
ARTICLES |
JW Winslow, A Shih, JH Bourell, G Weiss, B Reed, JT Stults and LT Goldsmith
Department of Obstetrics and Gynecology, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark 07103.
Unlike that of other species, which have only one gene encoding relaxin, the human genome contains two nonallelic genes for relaxin, designated H1 and H2, which encode markedly different relaxin peptides. Whereas human relaxin gene H2 is selectively expressed in the ovary, no ovarian expression of gene H1 has been detected. Since relaxin is actively produced in the human male, it is possible to postulate divergent gene expression of relaxin in the male and female. We examined this question directly through the structural determination of human seminal relaxin and its comparison with the structure of human luteal relaxin. Partially purified relaxin, prepared from pooled human seminal plasma which had been delipidated by extraction with acid acetone and hexane, subjected to two cycles of HPLC and an additional purification step by ion-exchange chromatography, was further purified by immunoaffinity chromatography, using a monoclonal antibody to the H2 relaxin A chain which cross-reacts with synthetic H1 relaxin, followed by an additional HPLC step performed on a C4 reverse-phase column. The recovered, purified relaxin was then analyzed by N-terminal gas-phase sequencing and fast atom bombardment mass spectroscopy for determination of the amino acid sequence and molecular ions of the A and B chains, respectively. The results demonstrate that the structure of the predominant relaxin in human semen plasma is derived from the product of the H2 gene, consisting of a N-terminal pyroglutamic acid A- 24 A chain and a mixture of B-26 and B-27 B chains. With the exception of degradation of the seminal relaxin B chain C-terminus, this structure is identical to the structure of human luteal relaxin. Therefore, both human seminal and luteal relaxin are products of the H2 gene.
This article has been cited by other articles:
![]() |
S. Feng, I. U. Agoulnik, N. V. Bogatcheva, A. A. Kamat, B. Kwabi-Addo, R. Li, G. Ayala, M. M. Ittmann, and A. I. Agoulnik Relaxin Promotes Prostate Cancer Progression Clin. Cancer Res., March 15, 2007; 13(6): 1695 - 1702. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Figueiredo, A. L. Mui, C. C. Nelson, and M. E. Cox Relaxin Stimulates Leukocyte Adhesion and Migration through a Relaxin Receptor LGR7-dependent Mechanism J. Biol. Chem., February 10, 2006; 281(6): 3030 - 3039. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Kamat, S. Feng, N. V. Bogatcheva, A. Truong, C. E. Bishop, and A. I. Agoulnik Genetic Targeting of Relaxin and Insulin-Like Factor 3 Receptors in Mice Endocrinology, October 1, 2004; 145(10): 4712 - 4720. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sudo, J. Kumagai, S. Nishi, S. Layfield, T. Ferraro, R. A. D. Bathgate, and A. J. W. Hsueh H3 Relaxin Is a Specific Ligand for LGR7 and Activates the Receptor by Interacting with Both the Ectodomain and the Exoloop 2 J. Biol. Chem., February 28, 2003; 278(10): 7855 - 7862. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. D. Bathgate, C. S. Samuel, T. C. D. Burazin, S. Layfield, A. A. Claasz, I. G. T. Reytomas, N. F. Dawson, C. Zhao, C. Bond, R. J. Summers, et al. Human Relaxin Gene 3 (H3) and the Equivalent Mouse Relaxin (M3) Gene. NOVEL MEMBERS OF THE RELAXIN PEPTIDE FAMILY J. Biol. Chem., January 4, 2002; 277(2): 1148 - 1157. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |